Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation
- PMID: 7525819
- DOI: 10.1002/jlb.56.5.616
Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation
Abstract
Exogenous, nonreplicating protein antigens (Ags) are usually taken up by antigen-presenting cells (APCs) via endocytosis or pinocytosis and enter the major histocompatibility complex (MHC) class II processing and presentation pathway. Although exogenous Ags are not processed and presented in the class I pathway by most cells, soluble proteins can enter the class I processing and presentation pathway if they are introduced directly into the cytoplasm of APCs. The purpose of these studies was to determine whether exogenous proteins could be processed and presented to T cells if they were delivered into cells by electroporation. The conditions for electroporation were optimized so that the viability of the electroporated cells was high, and the majority of electroporated cells had protein incorporated. Electroporated B cells not only presented exogenous ovalbumin to CD8+, class I MHC-restricted T cells but also stimulated CD4+, class II MHC-restricted T cells. Electroporated cells also primed Ag-specific cytotoxic T lymphocytes (CTLs) in vivo, stimulated CTL precursors in vitro, and served as target cells for lysis by Ag-specific CTLs, indistinguishable from transfected cells. Thus, electropermeabilized cells were structurally intact, and the introduced exogenous protein was processed and presented in association with both class I and class II MHC molecules. This approach is as efficient and reproducible as other techniques of delivering exogenous proteins into the intracellular processing pathways. These studies suggest that electroporation could be employed for the study of cell-mediated immunity to various exogenous proteins.
Similar articles
-
Presentation of exogenous antigen with class I major histocompatibility complex molecules.Science. 1990 Aug 24;249(4971):918-21. doi: 10.1126/science.2392683. Science. 1990. PMID: 2392683
-
Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.J Immunol. 1996 May 15;156(10):3721-6. J Immunol. 1996. PMID: 8621907
-
The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.J Exp Med. 1993 Sep 1;178(3):889-99. doi: 10.1084/jem.178.3.889. J Exp Med. 1993. PMID: 8102390 Free PMC article.
-
Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.Biol Chem Hoppe Seyler. 1994 Nov;375(11):731-6. doi: 10.1515/bchm3.1994.375.11.731. Biol Chem Hoppe Seyler. 1994. PMID: 7535058 Review.
-
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.Behring Inst Mitt. 1997 Feb;(98):197-211. Behring Inst Mitt. 1997. PMID: 9382741 Review.
Cited by
-
Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells.J Exp Med. 2000 Feb 21;191(4):613-24. doi: 10.1084/jem.191.4.613. J Exp Med. 2000. PMID: 10684853 Free PMC article.
-
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.Chem Rev. 2018 Aug 22;118(16):7409-7531. doi: 10.1021/acs.chemrev.7b00678. Epub 2018 Jul 27. Chem Rev. 2018. PMID: 30052023 Free PMC article. Review.
-
Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.Mol Biotechnol. 1996 Oct;6(2):105-13. doi: 10.1007/BF02740767. Mol Biotechnol. 1996. PMID: 8970166
-
Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake.J Exp Med. 1996 Sep 1;184(3):1179-84. doi: 10.1084/jem.184.3.1179. J Exp Med. 1996. PMID: 9064336 Free PMC article.
-
Facilitating the presentation of antigen peptides on dendritic cells for cancer immunotherapy using a polymer-based synthetic receptor.Medchemcomm. 2017 May 12;8(6):1207-1212. doi: 10.1039/c7md00188f. eCollection 2017 Jun 1. Medchemcomm. 2017. PMID: 30108830 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous